-
Signature
-
/s/ Robert Andrade
-
Stock symbol
-
FENC
-
Transactions as of
-
May 22, 2025
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
5/23/2025, 04:20 PM
Reporting Owners (1)
Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
Andrade Robert |
CHIEF FINANCIAL OFFICER |
C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK |
/s/ Robert Andrade |
2025-05-23 |
0001468308 |
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
FENC |
Common shares |
Options Exercise |
$41.9K |
+8.22K |
+5.47% |
$5.10 |
159K |
May 22, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
FENC |
Stock Options |
Options Exercise |
-$41.9K |
-8.22K |
-0.96% |
$5.10 |
851K |
May 22, 2025 |
Options |
8.22K |
$5.10 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: